|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor MS-275 in combination with 13-cis-retinoic acid in patients wit advanced solid tumors显示文摘 | PILI R RUDEK M ALTIOK S | 2006 | J Clin Oncol2006，24，18： | 1 |
| 2 | Bisphosphonates combined with sunitinib may improve the response rate,progression free survival and overall survival of patients with bone metastases from renal cell carcinoma显示文摘 | Keizman D Ish-Shalom M Pili R | | 0，，07： | 1 |
| 3 | The life cycle of valley fog, Part Ⅰ : Micrometeorological characteristics 显示文摘 | Pilie R J Mack E J Kocmond W C | 1975 | J Appl Meteor1975，14，3： | 1 |
| 4 | Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-beta-d- arabinofuranosylcytosine, mitoxantrone, and bevacizumab 显示文摘 | Karp J E Gojo I Pili R | 2004 | Clin Cancer Res2004，10，11： | 1 |
| 5 | Targeting tumor angiogenesis with histone deacetylase inhibitors 显示文摘 | Ellis L Hammers H Pili R | 2009 | Cancer Lett2009，280，2： | 1 |
| 6 | Idl regulates angiogenesis through transcriptional repression of thrombospondin-1显示文摘 | Volpert OV Pili R Sikder HA | 2002 | Cancer Ce112002，2，6： | 1 |
| 7 | Id1 regulates angiogenesisthrough transcriptional repression of thrombospondin-1显示文摘 | Volpert O V Pili R Sikder H A | 2002 | Cancer Cell2002，2，6： | 1 |
| 8 | Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias:therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab 显示文摘 | Karp JE Gojo I Pili R | 2004 | Clin Cancer Res2004，10，11： | 1 |
| 9 | Idl regulates angiogenesis through transcriptional repression of thrombospondin-1 显示文摘 | Volpert OV Pili R Sikder HA | 2012 | Cancer cell2012，2，6： | 1 |
| 10 | Idl regulates angiogenesis through transcriptional repression of thrombospondin-1显示文摘 | Volpert O V Pili R Sikder H A | 2002 | Cancer Cell2002，2，47： | 1 |
| 11 | Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias:therapy with sequential 1-beta-d-arabino -furanosylcytosine,mitoxantrone,and bevacizumab显示文摘 | KARP J E GOJO I PILI R | 2004 | Clin Cancer Res2004，10，11： | 1 |
| 12 | Is HIF-1 alpha a valid therapeutic target显示文摘 | Pili R Donehower RC | 2003 | J Natl Cancer Inst2003，95，： | 1 |
| 13 | Idl regulates angiogenesis through transcriptional repression of thrombospondin-1 显示文摘 | Volpert OV Pili R Sikder HA | 2002 | Cancer Cell2002，2，： | 1 |
| 14 | Targeting tumor angiogenesis with histone deacetylase inhibitors显示文摘 | Ellis L Hammers H Pili R | 2009 | Cancer Letters2009，280，： | 1 |
| 15 | Targeting tumor angiogenesis with histone deacetylase inhibitors 显示文摘 | Ellis L Hammers H Pili R | 2009 | Cancer Lett2009，280，2： | 1 |
| 16 | Histone deacetylase inhibitors: advancing therapeutic strategies in hematological and solid malignancies 显示文摘 | Ellis L Pili R | 2010 | Pharmaceuticals (Basel)2010，3，8： | 1 |
| 17 | Targeting tumor angiogenesis with his- tone deacetylase hahibitors显示文摘 | Ellis L Hammers H Pili R | 2009 | Cancer Lett2009，280，2： | 1 |
| 18 | A simple, quantitative method for assessing angiogenesis and anti - angiogenic agents using reconstituted basement membrane, heparin, and fihroblast growth factor显示文摘 | Passaniti A Taylor RM Pili R | 1992 | Lab Invest1992，67，4： | 1 |
| 19 | Phase lI ran- domized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic meta- static castrate-resistant prostate cancer显示文摘 | Pili R Haggman M Stadler W M | 2011 | J Clin Oncol2011，29，32： | 1 |
| 20 | Is HIF-1α a valid therapeutic target显示文摘 | Pili R Donehower RC | 2003 | J Natl Cancer Ins2003，95，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员